Latest Health News

Alcidion has secured its first contract in Wales with Hywel Dda University Health Board, deploying its Miya Precision Platform to enhance patient flow and clinical communication over five years.

Macquarie Group’s 3Q25 trading update reveals strong growth in its annuity-style businesses, while markets-facing segments face pressure from subdued commodity markets, resulting in a mixed financial performance for the year to date.

Breville Group Limited reported a robust half-year performance with 10.1% revenue growth and a 16.1% rise in net profit, driven by strong coffee category sales and strategic product launches. Despite macroeconomic headwinds and tariff concerns, the company maintains a confident outlook for FY25.

SGH Limited has announced a fully franked ordinary dividend of AUD 0.30 per share for the six months ending December 2024, signalling steady financial health and shareholder returns.

Vulcan Steel Limited reported a 12.6% revenue decline and a 64.8% drop in net profit for the first half of FY25 amid challenging market conditions. Despite this, the company achieved a 10% return on capital employed and is positioning itself for growth as economic recovery signs emerge.

Pro-Pac Packaging has updated its quarterly cash flow report, highlighting a net cash outflow from operations and outlining plans to improve margins and secure longer-term funding.

WAM Global reports a robust 23.7% increase in its investment portfolio for the year ending December 2024, prompting a rise in fully franked dividends including a special payout. The company’s strong financial results underscore its confidence in sustained growth and shareholder returns.

Wellnex Life Limited has announced a non-renounceable entitlement offer to raise approximately $22.1 million at $0.65 per share, supporting its planned AIM listing and strategic growth initiatives.

BTC Health has transformed its decade-long license agreement with Arna Pharma into an indefinite partnership, gaining royalties from Singapore and Malaysia sales and first rights to new pharmaceutical products in Australia and New Zealand.

WAM Global Limited has announced a special fully franked dividend of AUD 0.04 per share, reflecting strong profitability for the half-year ending December 2024. The dividend will be paid on July 31, 2025, with a Dividend Reinvestment Plan available to shareholders.

Micro-X Limited's trading suspension has been lifted following its announcement of an equity raising, signaling renewed market activity for the medical technology firm.

Keybridge Capital has been hit with an immediate $4.6 million loan repayment demand from Yowie Group, triggered by delays in its capital raising efforts obstructed by WAM Active Limited.